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Abstract 
This European Respiratory Society (ERS) statement provides a comprehensive overview on 
physical activity in patients with chronic obstructive pulmonary disease (COPD).  
Methods: A multidisciplinary Task Force of experts representing the ERS Scientific Group 
01.02 „Rehabilitation & Chronic Care‟ determined the overall scope of this Statement through 
consensus.  Focused literature reviews were conducted in key topic areas and the final 
content of this Statement was agreed upon by all members.  
Results: The current knowledge regarding physical activity in COPD is presented, including 
the definition of physical activity, the consequences of physical inactivity on lung function 
decline and COPD incidence, physical activity assessment, prevalence of physical inactivity 
in COPD, clinical correlates of physical activity, effects of physical inactivity on 
hospitalizations and mortality, and treatment strategies to improve physical activity in patients 
with COPD.  
Conclusions: This Task Force identified multiple major areas of research that need to be 
addressed further in the coming years, including, but not limited to, the disease-modifying 
potential of increased physical activity and to further understand how improvements in 
exercise capacity, dyspnea, and self-efficacy  following interventions may translate into 
increased physical activity. 
Recommendation: The Task Force recommends that this ERS Statement will be reviewed 
periodically (e.g.every 5-8 years).    
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1. Introduction  
Chronic obstructive pulmonary disease (COPD) is a highly prevalent chronic respiratory 
disease affecting about 10% of the adult population above 40 years of age (1). In addition to 
progressive chronic airflow limitation, patients with COPD commonly have multiple extra-
pulmonary effects and comorbidities, which are associated with physical inactivity (2) (3). 
The “Global Initiative for Chronic Obstructive Lung Disease” has recommended regular 
physical activity for all COPD patients (2). However, the clinical relevance of regular physical 
activity has not been addressed in depth. The purpose of this Official European Respiratory 
Society (ERS) Statement is to highlight the existing science regarding physical (in)activity in 
patients with COPD, including, but not limited to, its prevalence, determinants, 
consequences, measurement, and potential treatment.  
 
2. Methods  
An international group of pulmonologists, physiotherapists, movement scientists, exercise 
physiologists, health psychologists, social psychologists, and epidemiologists knowledgeable 
in the area of physical activity and/or COPD research was assembled into a Task Force by 
the leadership of the ERS Scientific Group 01.02 „Rehabilitation & Chronic Care‟. 
Contributors searched the scientific literature (PubMed and Database of the Cochrane 
Collaboration) for original studies and systematic reviews relevant to the topic Selection of 
relevant studies and reviews was based on the expertise of the contributors. Draft 
contributions were shared among committee members, reviewed and revised iteratively. 
Members were vetted for potential conflicts of interest according to the policies and 
procedures of ERS. This document represents the consensus of these Task Force members. 
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3. Definitions 
Physical activity can be defined as any bodily movement produced by skeletal muscles that 
results in energy expenditure (4). Physical activity is a complex behavior that can be 
characterized by type, intensity, duration, patterns, and symptom experience. Exercise is a 
subset of physical activity. Exercise is physical activity that is planned, structured, repetitive, 
and purposeful (4). Physical activity also includes, but is not limited to, leisure-time, 
domestic, and occupational activities (4;5). Activities of daily living are another subset of 
physical activity and this term refers to a set of basic, everyday tasks required for personal 
self-care and independent living (6;7).  
While physical inactivity can be defined simply as „an absence of physical activity‟ (8), it is 
commonly used to represent a level of physical activity that is below an optimal or specified 
threshold. This concept rests on the strong evidence that lower levels of physical activity are 
related to poor health and predict negative health outcomes (9). In general, a healthy 
individual can be considered as physically inactive if either of the following criteria is not met: 
(1) 30 minutes of at least moderate-intensity physical activity on five or more days every 
week; (2) 20 minutes of vigorous-intensity physical activity on at least three days every week; 
or (3) an equivalent combination, which can also be accumulated in shorter bouts usually 
lasting 10 minutes of moderate (3 times 10 minutes) or vigorous (2 times 10 minutes) 
exercise (10;11). This represents a framework on which to base recommendations for 
physical activity promotion. However, the recommended intensity and duration of physical 
activity for the elderly may be different (12). Furthermore, the extent to which these 
recommendations apply to persons with COPD is currently unknown. 
In recent years, attention has been raised regarding the adverse health effects of a 
sedentary lifestyle (13). A sedentary lifestyle is characterized by behaviors that do not 
increase skeletal muscle energy expenditure substantially above the resting level (14). 
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Sedentary individuals expend less than 10% of their total daily energy expenditure in 
performing moderate- or high-intensity activities (15).  
4. Consequences of physical inactivity in general population and in chronic diseases 
other than COPD  
Physical inactivity is a fundamental characteristic of many chronic diseases, both as a cause 
and as a consequence. Evidence suggests that reduced physical activity predisposes to 
greater incidence of cardiovascular disease (16;17), obesity (18), diabetes (19;20), cancer 
(21), dementia (22), and physical disability (23). In addition to its effect on development of 
chronic disease, physical inactivity may develop or worsen as a result of many diseases, 
owing to the sequelae of the disease and/or the associated reduction in physiological 
reserve. These effects of physical inactivity to both potentiate and develop from chronic 
disease likely explain the fact that reduced physical activity, measured either subjectively or 
objectively, is associated with higher overall mortality rates in the elderly (24;25). The exact 
mechanisms whereby physical inactivity interacts with anatomical and physiological changes 
related to aging and other pathological co-factors to contribute to the evolution of disease or 
subsequent morbidity or mortality, however, is poorly understood within the human 
population. 
 
5. Consequences of physical inactivity on lung function decline and COPD incidence  
Several population-based epidemiological studies have assessed the longitudinal effect of 
regular physical activity on lung function decline or COPD incidence (26-30); their main 
characteristics and results are summarised in Table 1. Briefly, all studies show an inverse 
relationship between physical activity levels and the magnitude of lung function decline in at 
least one of the population subgroups or physical activity variables studied. However,  the 
association between lower physical activity levels and faster lung function decline is not 
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consistent across all population subgroups or physical activity variables. Potential 
explanations for such inconsistencies include selection bias, lack of adjustment for potential 
confounders, and lack of consideration of changes in physical activity level during follow-up. 
Only one study overcomes such limitations and, interestingly, shows beneficial effects of 
regular physical activity on lung function decline and COPD risk in active smokers but not in 
former or never smokers (29;30).  
 
6. Physical activity assessment  
6.1 Questionnaires 
The physical activity of patients with COPD can be assessed using questionnaires. These 
instruments are commonly used in epidemiological studies and large clinical trials because 
they are inexpensive and easy to use (31). A variety of questionnaires exist that capture 
different aspects of physical activity such as amount, type, intensity, symptom experience, 
and limitations in the performance of „activities of daily living‟ (31). The selection of a 
questionnaire to measure physical activity requires that the specific questionnaire fits the 
study aim, is properly developed and has strong psychometric properties, e.g., validation, 
test-retest reliability and responsiveness to change (32). In the specific case of COPD 
studies, additional criteria could be considered to improve validity of the questionnaire, such 
as the inclusion of information on low-intensity activities (31;33), or the availability of a 
version for interviewer-based administration (34). Other practical issues include the 
availability of a culturally validated version, the time required for questionnaire administration, 
and the ability to compare outcome levels across studies.  
Recent systematic reviews have assessed all questionnaires available to measure physical 
activity in the elderly or chronically ill patients (35;36). From the 104 questionnaires identified 
in these systematic reviews, 15 were developed for use in patients with COPD. Validity was 
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assessed in 85% of these instruments, test-retest-reliability in 69%, responsiveness in only 
19%, and none of the instruments was based on a conceptual framework (37). A current 
Innovative Medicines Initiative project is filling this gap by developing a valid Patient 
Reported Outcome tool (PROactive) capturing physical activity experience in COPD 
(http://www.proactivecopd.com).  
A common methodological issue is recall bias, which may become a limitation if not 
addressed in the development and validation process. Garfield et al assessed 4 
questionnaires against physical activity measured directly by accelerometry and found that 
while the Stanford Seven-Day Physical Activity Recall questionnaire could identify patients at 
both extremes of physical activity the other 3 had a poor relationship with directly measured 
activity only (38). Also in two other studies the relationship between questionnaire-derived 
physical activity measures and accelerometer-derived physical activity measures was either 
not given (39) or did not allow to reliably identify extremely inactive patients (40). .  
Despite limitations of questionnaires when used on an individual level, some questionnaires 
might be used to measure physical activity in groups of patients with COPD. However, the 
choice depends on matching the question to be addressed with the psychometric properties 
of the instrument. 
 
6.2 Step counters 
Pedometers are small, lightweight, portable and nonintrusive devices which measure the 
number of steps performed in a given period of time. From that metric estimates of distance 
and energy expenditure can be made (31). Many pedometers are available, and variability 
exists not only in cost but also in mechanism of step detection, data storage, and sensitivity. 
Pedometers are most accurate at step counting, less accurate in distance estimates, and 
even less accurate at estimating energy expenditure (41). Pedometers may underestimate 
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the number of steps and energy expenditure during walking at slow speed, which is typical in 
patients with COPD (42-44). This may limit their accuracy in patients with moderate-to-very 
severe disease. However, pedometers may have positive role as a motivational tool aiming 
to increase daily activity, especially in addition to other combined interventions (45-47). 
6.3 Activity monitors  
Accelerometers are electronic portable devices that are worn on the body to detect 
acceleration and thereby reflect bodily movement. They quantify activity counts, and may 
provide an estimate of time spent above or below a pre-specified activity level, number of 
steps, and energy expenditure (31). The use of accelerometers has received increasing 
interest since they add objective data which cannot be obtained from questionnaires or 
pedometers.  
Accelerometers can detect movement along one axis (uni-axial accelerometers), two axes 
(bi-axial accelerometers), or three axes (tri-axial accelerometers). Uni-axial devices provide 
information similar to pedometers, but with the advantage of assessing acceleration in 
addition to simply detecting steps. Bi-axial and tri-axial devices allow for detection of 
movement in a wider range of physical activities, and are therefore more sensitive than uni-
axial devices (48). Activity monitors sometimes combine accelerometers with other 
physiological sensors (such as heart rate, skin temperature) or are used in conjunction with 
positioning systems with the objective of increasing their accuracy to estimate daily physical 
activity and energy expenditure (49-51).  
The validity of activity monitors for assessment of physical activity in patients with COPD has 
been the subject of many investigations in recent years (31;39;42;43;49;52-61). Two studies 
in COPD patients recently investigated the validity of six widely used accelerometers in 
comparison to the „gold standards‟ of indirect calorimetry and doubly-labeled-water (62;63). 
Among the six devices, the DynaPort MiniMod , the Actigraph GT3X and the SenseWear 
Armband (all employing triaxial accelerometers) were valid and responsive for use in COPD 
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(62;63). These devices were demonstrated to be valid in other studies in COPD as well 
(42;43;49;52;54-56;58).  
Several factors may influence the outcome of physical activity monitoring. Vibration from 
vehicle travel can falsely elevate activity counts measured by some devices, although this 
may be reduced by filtering the accelerometer signal (64). The number of assessment days 
and hours of use per day are also important factors that may influence the reliability of the 
physical activity assessment (65;66). Interestingly, compared to the other days of the week 
especially Sundays seem to be days of less physical activity in GOLD stage I to III patients 
(65)A recent study demonstrates that for cross-sectional analyses two to three days are 
sufficient for reliable measurement of physical activity in patients GOLD stage IV, whereas 
up to 5 days of measurement are required in patients with GOLD stage I (65). For 
measurements that aim to assess longitudinal changes 4 days were shown to be sufficient to 
demonstrate treatment effects following pulmonary rehabilitation in moderate to severe 
COPD, when weekends were excluded from the analysis (67). 
The use of accelerometers certainly presents limitations. It should be noted that there is little 
uniformity in output from the various types of accelerometers, what makes it difficult to 
compare studies using different devices (68). Another limitation is that estimates of energy 
expenditure for individual patients may be inaccurate, especially among those with functional 
limitations due to chronic diseases that affect walking speed and efficiency of movement 
(69). Furthermore, purchase costs vary considerably between devices.  
 
6.4 Doubly labeled water  
The doubly labeled water (DLW) method provides an indirect assessment of total energy 
expenditure by the body over a substantial period of time (e.g. 2 weeks). The technique is 
described elsewhere (70). Briefly, known doses of deuterium (2H2O) and 
18O are ingested 
(2H2O & H2
18O). The deuterium washes out of the body through the urine, whereas the 18O is 
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eliminated as urine water and CO2. The difference between the wash out of the two (typically 
measured in urine samples) provides an estimate of CO2 production by the body, which can 
be converted to energy expenditure (71).  
The biggest drawback of the technique in the context of physical activity assessment in 
COPD is that it does not allow separating energy expenditure linked to physical activity and 
energy expenditure linked to basal metabolic rate or diet induced metabolism. Thus although 
the DLW technique is used  to estimate total energy expenditure in patients with 
COPD(63;72;73) its ability to estimate physical activity is compromised by a number of 
assumptions that may be correct for healthy subjects but not for patients with COPD. For 
example one study used DLW in severe COPD and concluded that active energy 
expenditure was even higher in COPD compared to controls, which might be related to the 
increased oxygen cost of breathing and decreased mechanical efficiency in patients with 
COPD(72). On the other hand, actual physical activity levels are lower in patients with COPD 
(65). The DLW technique should likely be restricted to questions on caloric balance in 
patients with COPD rather than questions concerning the amount and intensity of physical 
activity. It can be questioned whether the technique should remain the „gold standard‟ to 
validate monitors that measure the amount and intensity of movement in COPD, even though 
DLW will very likely remain a „gold standard‟ for measuring the caloric cost of physical 
activity. 
 
7. Levels of physical activity in patients with COPD  
Patients with COPD have significantly lower levels of physical activity as compared to 
healthy controls (65;74-81). Existing data shows that time spent walking is significantly lower 
in COPD patients compared to healthy, age-matched persons (74;76;77;80;82). These 
findings appear to be consistent across settings, cultural background, geographic area and 
methods used to measure physical activity. In addition, movement intensity of patients with 
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COPD is lower compared to age-matched healthy subjects, which indicates that patients with 
COPD walk at a slower pace (74).  Current data suggest that patients with COPD reduce 
their physical activity early in the course of the disease (83-85). Accordingly, most patients 
do not meet currently recommended physical activity levels. For example in one study only 
26% of 177 patients with a mean FEV1 52% predicted achieved at least 30 consecutive 
minutes of moderate intensity activity on at least 5 days; this increased to 50 % if the 30 
minutes were accomplished in bouts of at least 10 minutes each (86). Corroborating these 
results, another study reported that only 29% of 73 patients with COPD achieved a mean of 
at least 30 minutes of moderate physical activity summed up throughout the day (87). 
Compared to controls COPD patients had a reduction by 50 % of their minutes of moderate 
physical activity per day, which was even more reduced when bouts of at least 10 min were 
compared between controls and COPD patients (88).   
 
8. Factors associated with physical activity in COPD   
This section addresses associations between physical activity and clinical characteristics of 
patients with COPD, such as disease severity, comorbidities, exacerbations, and behavioral 
factors. Since most of the studies are cross-sectional it is not possible to draw conclusions 
regarding the directionality of the established associations (89). It should be acknowledged 
that in general, physical activity is dependent of many factors, which include biological, 
behavioral, genetic, social, environmental, cultural and policy factors (90). In this section we 
will discuss those aspects that are specifically studied in COPD. 
 
8.1 Lung function  
FEV1 shows a weak to moderate positive association with objectively measured physical 
activity in patients with COPD (39;65;74;77;79;80;91;92); Table 2). In general, FEV1 explains 
only a small proportion of the variation in physical activity in subjects with COPD. Directly 
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measured maximal voluntary ventilation may provide an increased correlation with physical 
activity in this population (92). Fewer studies have investigated the relationship between 
physical activity and other lung function measures. While three studies found weak-to-
moderate positive associations between physical activity and diffusion capacity (74;80;93), 
one study showed a strong and independent linear association (94). A robust inverse 
association was found between dynamic hyperinflation (measured in the laboratory during 
cardiopulmonary exercise test on a stationary cycle ergometer) and physical activity (95). 
Overall, while increasing severity of lung function impairment is associated with reduced 
physical activity in subjects with COPD, the relationship is relatively weak. Therefore, levels 
of physical activity cannot be accurately predicted from resting lung function parameters.  
8.2 Exercise performance  
Physical fitness, which can be measured by various exercise tests, comprises a set of 
attributes that relates to the ability to perform physical activity (4). Accordingly, most 
studies in COPD have found moderately positive associations between either 6-minute 
walk distance or peak work rate in an incremental exercise test and objectively measured 
physical activity (40;65;74;79;96) (Table 3).  
Two studies evaluated the predictive power of the 6-minute walk distance to identify 
physically inactive COPD patients with an objectively measured physical activity level 
lower than 1.4 (i.e. less that 40% of total daily energy expenditure is related to physical 
activity). In both studies 6-minute walk distance - even though moderately associated 
with physical activity - was found to be of limited value to reliably identify physically 
inactive COPD patients (40;65).  
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8.3 Self-efficacy 
Self-efficacy, an individual‟s belief in his or her capability of performing a specific task in a 
specific situation, is influenced by expectations of ability to perform the task and its outcome 
(97). Theoretically, higher levels of self-efficacy may be associated with increased physical 
activity; and higher levels of physical activity may result in enhanced self-efficacy belief. 
However, self-efficacy for walking, assessed in COPD using the Self-Efficacy Questionnaire 
– Walking (SEQ-W) instrument, was only weakly associated with  objectively measured 
physical activity (91). Furthermore, in another study of 165 patients with COPD, general self-
efficacy as measured with the General Self-Efficacy Scale (SES6) was not associated with 
physical activity (98).  
8.4 Socio-demographic factors and environment  
Several socio-demographic and environmental factors including ethnicity, socioeconomic 
status, job availability, education level, patient choices about where to live, and seasonal 
variations in temperature and humidity have the potential to influence performance of daily 
physical activity among persons with COPD.  
Among healthy adults, lower physical activity levels have been associated with lower 
socioeconomic status, lower education level and non-Caucasian race (99-101). However, 
this may not be the case for patients with COPD, since two studies have demonstrated a 
relationship between lower physical activity levels and higher socioeconomic status 
(102;103). In these studies, it is difficult to distinguish the impact of socioeconomic status 
from that of other influences, such as geographic location and ethnic and cultural differences, 
but it is possible that increased dependence on walking and public transportation among 
persons of lower socioeconomic status accounts for the findings. Also, both studies focused 
on persons with severe airflow limitation; hence the findings may not be applicable to 
patients with less severe lung function impairment.  
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Weather, climate and altitude conditions can also influence physical activity levels among 
persons with COPD. Extremes of heat or cold and or high environmental levels of 
particulates or other air pollutants can trigger increased symptoms, bronchoconstriction and 
acute exacerbations (104-106) and may pose a barrier to exercise and activity adherence 
(107;108). Accordingly, seasonal variations in daily physical activity have been reported 
(93;109-111), with a tendency for lower activity during periods with lower temperature. High 
altitude environments may also influence physical activity levels, since elevation in altitude 
leads to worsening resting and/or exercise hypoxemia and reduced exercise tolerance 
among patients with COPD (112). Geographical location per se may not strongly influence 
activity levels (e.g., independently of other factors such as climate, altitude or socioeconomic 
status) as no significant differences in physical activity were observed among patients with 
varying severity of COPD across diverse geographic locations in Europe and the United 
States (78;79). Finally, physical activity levels may be influenced by the day of the week; total 
activity and activity intensity were lower on Sundays or weekend as compared to other days 
(63;65).  
8.5 Exacerbations of COPD 
Physical activity is dramatically reduced during and after hospitalization due to an 
exacerbation of COPD (113;114). Furthermore, recovery time is prolonged over several 
weeks and physical activity may not return to pre-exacerbation activity levels (113;114).  
Even patients with milder exacerbations, which do not require hospitalization, tend to stay 
indoors during the exacerbation period (115). Moreover, patients with a history of frequent 
exacerbations reduce their time spent outdoors at a faster rate compared with those with 
infrequent exacerbations, and thus are more likely to become housebound (115). This is 
confirmed by another study demonstrating that a history of more than one exacerbations is 
correlated with lower physical activity levels (79).  
8.6 Comorbidities 
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Comorbidities are common in COPD (116-118) and may independently impact physical 
activity levels. A cross-sectional study of 170 patients with COPD  demonstrated that left 
ventricular cardiac dysfunction (assessed by elevated NT-pro-BNP and echocardiographic 
assessment of diastolic function) was associated with reduced physical activity levels, 
independent of COPD severity assessed by GOLD stage or the multidimensional BODE 
score (119). In this study, depression, anemia, systemic arterial blood pressure, and 
nutritional depletion were not associated with reduced physical activity levels (119). In the 
same cohort physical activity levels were significantly lower among patients with metabolic 
syndrome and COPD across all GOLD stages as compared with the patients without 
metabolic syndrome (120). It is not yet clear, which of the components of the metabolic 
syndrome contributed to this finding. For instance, obese COPD patients have lower activity 
levels compared to underweight- and normal weight patients (121;122). Furthermore, 
diabetes is strongly associated with inactivity in COPD, independent of other confounders 
(102). In a cohort of newly diagnosed COPD patients, physical inactivity was more strongly 
associated with the presence of comorbidities compared with airflow obstruction (123).  
Quadriceps muscle strength and mass, which are commonly reduced in patients with COPD, 
are positively correlated with physical activity in several studies (74;79;85). In one study 
quadriceps muscle strength was predictive of physical activity, independent of FEV1 (79). In 
contrast, handgrip strength did not correlate with physical activity in patients with COPD 
(94;119).  
Mood disturbances such as symptoms of anxiety and depression are highly prevalent in 
patient with COPD (124). Of the six studies examining the relationship of physical activity 
and depression in patients with COPD (79;80;119;125-127) only two found significant 
associations (80;127). In one study higher levels of anxiety were associated with higher 
levels of physical activity whereas more depressive symptoms were associated with lower 
physical activity only when anxiety was part of the statistical model (127).  
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8.7 Systemic inflammation  
In the general population a growing body of evidence demonstrates that physical activity, 
inflammation and immunity are tightly linked, with regular moderate physical activity reducing 
systemic inflammation (128-131). Potential mechanisms underlying these observations 
include the release of anti-inflammatory myokines by contracting skeletal muscles (132). In 
COPD, four studies demonstrated that higher levels of low-grade systemic inflammation are 
associated with lower levels of physical activity even after adjusting for relevant confounders 
(79;94;119;133). Whether anti-inflammatory mechanisms of regular physical activity or 
COPD-specific mechanisms of systemic inflammation underlie the associations of systemic 
inflammation and physical activity in COPD needs to be elucidated in further longitudinal 
studies (134).  
8.8 Health status  
Various assessments of health status have been related to physical activity measurements in 
patients with COPD. Most studies showed that an impaired health status assessed either by 
generic or disease-specific instruments is weakly to moderately related to a lower amount 
and intensity of physical activity (79;91;102;135;136). Changes in physical activity over time 
parallel trends in health status (137). Since most health status questionnaires have items 
addressing physical activity this could obviously affect these relationships.  
8.9 Symptoms 
Breathlessness on exertion is the primary symptom limiting exercise, which in turn leads to 
reduced physical activity in patients with COPD (138). Accordingly, patients‟ perception of 
breathlessness on exertion is reported to be a barrier for participation in exercise and daily 
activities of daily living (110;139). Indeed, greater levels of dyspnoea as measured by the 
modified Medical Research Council Dyspnoea Scale are related to lower levels of physical 
activity in patients with COPD (65;79).  
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Also fatigue is reported to be a frequent symptom in patients with COPD (140). There is one 
study that evaluated the association of fatigue assessed by the Functional Assessment of 
Chronic Illness Therapy - Fatigue questionnaire and physical activity. After adjusting for 
several confounders physical activity was demonstrated to be associated with fatigue in 
patients with COPD.  (79). Whether and to what extent pain symptoms may affect physical 
activity in patients with COPD remains currently unknown. 
 
9. Effect of physical inactivity on hospitalizations in patients with COPD 
To date seven prospective longitudinal studies have assessed the association between 
levels of regular physical activity and hospital admission or readmission due to COPD 
exacerbations (30;113;141-145). All studies consistently showed a statistically significant 
association of low physical activity levels with increased risk of hospitalizations. Although all 
studies reported associations adjusted for confounders, just one study adjusted for previous 
COPD hospitalizations, which is one of the most important risk factor for readmission (146).  
Importantly, the studies have shown that the amount of regular physical activity needed to 
obtain a significant effect on admissions due to COPD is relatively small, equivalent to 
walking or cycling 2 hours per week (30;113;141-145).  
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10. Effects of physical inactivity on survival in COPD 
Three longitudinal studies with a follow-up of 3 to 12 years have demonstrated that low levels 
of physical activity predict all-cause mortality in patients with COPD after controlling for 
relevant confounding factors (144;145;147). The relationship was consistent across differing 
settings, patient characteristics, and methods used to measure physical activity. In one study 
that separated respiratory-related from cardiovascular and all-cause mortality, the greatest 
effect was on the former (144). Recently, an assessment of physical activity has also been 
included as a prognostic factor in a multidimensional prognostic score for stable COPD 
patients (148). 
Whether and to what extent improvements in physical activity levels may lower the risk of 
dying remains unknown in patients with COPD. Furthermore, it seems reasonable to 
hypothesize that patients who have a decline in physical activity over time have a worse 
prognosis compared to those patients who remain physically active.  
 
11. Treatment strategies to improve physical activity  
11.1 Pharmacologic therapy 
While it is well-known that bronchodilators improve dyspnoea and exercise tolerance, only 
few studies have investigated the impact of bronchodilator therapy on physical activity (149-
151). Two studies had positive results with regard to improvements of physical activity 
following bronchodilator treatment. Of these, one study (23 patients)  was a non-randomized 
open-label study of a long-acting beta-agonist in a small number of patients (150), while the 
other study was a retrospective subgroup analysis (151). By contrast, two randomized, 
placebo-controlled, multicenter study could not demonstrate a change in physical activity 
following therapy with a long-acting bronchodilator (149;152). Therefore, it remains currently 
unknown, whether bronchodilator therapies that are known to improve exercise capacity will 
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also either improve physical activity or prevent deterioration of physical activity over time in 
patients with COPD.  
11.2 Ambulatory oxygen therapy 
Oxygen therapy improves exercise tolerance in hypoxemic COPD patients, but whether 
activity levels are also enhanced is unclear.  A small, randomized trial of replacing heavier 
oxygen tanks with lightweight ambulatory oxygen therapy failed to detect improvements in 
activity monitor assessments of physical activity over a 6 month period (153).   
 
11.3 Pulmonary rehabilitation  
Pulmonary rehabilitation is a “comprehensive intervention to improve the physical and 
psychological condition of people with chronic respiratory disease and to promote the long-
term adherence to health-enhancing behaviors” (154). Pulmonary rehabilitation has been 
demonstrated clearly to reduce dyspnea, increase exercise capacity and improve quality of 
life in patients with COPD. Increases in exercise capacity in combination with behavioral 
change may also have the potential to increase physical activity in patients with COPD. 
Despite this rationale the 10 studies that evaluated the effect of pulmonary rehabilitation on 
physical activity (80;82;155-162) have yielded inconsistent results; four showed an increase 
of physical activity (80;160-162) and six failed to do so (82;155-159). In the negative studies, 
the lack of improvement in physical activity was observed despite a concomitant increase in 
exercise capacity and quality of life. A systematic review and meta-analysis of single-group 
and randomized trials of the effect of exercise training (not necessarily pulmonary 
rehabilitation) on physical activity concluded that this intervention conferred a significant but 
small increase in this outcome (163).    
 
11.4 Behavior changes, feedback, counseling 
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Solely increasing the exercise capacity of patients with COPD may be insufficient to increase 
participation in self-directed leisure time activity (47;80;82;155;157-162;164). Widespread 
acknowledgment of the exercise maintenance problem has led to the identification of 
behavioral factors related to participation in daily physical activity and to the development of 
interventions targeting these factors.  
Interventions including self-monitoring of activity behavior using activity monitors in 
combination with behavioral counseling in patients with COPD might have the potential to 
change physical activity behavior (45-47;165-167). However, the evidence base is weak 
since only few studies have been conducted using small samples (46;47) often without a 
control group (45;165;166). Larger studies with long term follow up are needed in patients 
with COPD.  
Key components that increase the effectiveness of behavioral interventions have already 
been summarized in several meta-analyses and international guidelines (168-172) and 
include mobilizing social support, using well-described/established behavior change and self-
regulatory techniques (self-monitoring, stimulus control, problem solving, relapse prevention 
management, goal setting, self-reinforcement, providing feedback on performance and 
developing action plans), providing higher contact time or contact frequency, and assessing 
the readiness / motivation to change (168;170). Motivational interviewing techniques have 
further been recommended as a collaborative communication approach (168).  
11.5 Summary of treatment strategies to improve physical activity  
To date, only a few randomized controlled trials have studied the efficacy of pharmacologic 
or non-pharmacologic treatment strategies on daily physical activity in patients with COPD. 
Therefore, there is an urgent need for additional well-designed trials. Based on the correlates 
of physical activity, it seems reasonable to focus in future studies on physical, non-physical 
and environmental factors to improve physical activity in patients with COPD. Moreover, 
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future trials should not only focus on improvements of physical activity but also on the 
prevention of loss of physical activity.  
12. Moving forward 
The scientific foundation regarding the clinical importance of assessing and improving 
physical activity in patients with COPD has grown considerably in the last decade. 
Nevertheless, many questions remain unanswered and the methodology of physical activity 
assessment needs to be further standardized. Therefore, this Task Force identifies the 
following major areas that need to be further addressed in the coming years:  
1. In addition to smoking cessation the disease-modifying potential of increased physical 
activity in smokers without COPD and in patients with all degrees of airflow limitation 
should be explored. 
2. Further understanding is needed regarding the  concepts to optimize the impact of 
the pharmacological and non-pharmacological interventions that aim to maintain or 
increase physical activity levels in patients with COPD. 
3. Research should be undertaken to understand how improvements in exercise 
capacity, dyspnea, and self-efficacy  following intervention (e.g. pulmonary 
rehabilitation, pharmacological therapy) might translate into increased physical 
activity. 
4. The methodology to measure physical activity needs to be further standardized and 
formal guidance on that should be provided in future. Such methodologies could rely 
on objective and accurate assessment of physical activity, patient reported 
assessment of physical activity experience or combination thereof.  
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Table 1. Studies on physical inactivity and lung function decline or COPD incidence. 
Study  Design and 
setting 
Number of 
subjects and 
follow-up 
Subjects‟ characteristics Physical 
activity 
assessment 
Outcome(s) Main Results 
Jakes et al.  
[ref 26] 
Population-
based cohort 
 
UK 
n=12,283 
mean 3.7 
years follow-
up 
45% men 
mean age: 59 (9) y 
mean FEV1: 3.0 (0.7) L in 
men, and 2.2 (0.5) L  in 
women 
 
Standardised 
questionnaire 
FEV1 decline 
(mL/y) 
Climbing more stairs is associated with slower FEV1 decline in 
women (-0.31, -0.11, -0.03, and 0.04% change in FEV1 in none, 1-
5, 6-10 and >10 flights per day, p-for-trend<0.004).   
 
Participation in vigorous leisure time activities is associated with 
slower FEV1 decline in women (-0.22, -0.34, 0.27, and 0.03% 
change in FEV1 in none, <0.25, 0.25-1, and >1 h per week, p-for-
trend<0.004).  
 
Based on a linear regression model adjusted for age, smoking 
status, and percent change in weight. 
 
No association found in men. 
Pelkonen et 
al. [ref 27] 
Cohort of rural 
men with a 
high physical 
activity level 
n=186 
25 years 
follow-up 
100% men 
mean age: 54 (5) y 
mean FEV0.75: 2.9 (0.6) L 
Validated 
questionnaire 
FEV0.75 decline 
(mL/y) 
Decline in FEV0.75 over 25 years was -44.4, -40.5, and -36.5 mL/y, 
p-for-trend=0.035 for low, middle, and high physical activity. 
 
Based on a linear regression model adjusted for age, height and 
39 
 
 
Finland 
smoking habits. 
Cheng et al.  
[ref 28] 
Convenience 
sample from a 
clinic 
 
USA 
n=5707 
mean 1.6 
years follow-
up 
87% men 
age range 25-55 years 
Self-report FEV1 and FVC 
decline (mL/y) 
Men who during the follow-up remained in the active category 
increased 50ml of FEV1 and 70mL of FVC while subjects who 
remained in the sedentary group reduced 30 and 20 mL of FEV1 
and FVC, respectively. 
 
Based on generalised least squared regressions adjusted for 
smoking and drinking habit change, age, baseline height, baseline 
lung function levels, and follow up time. 
 
No association found in women. 
40 
 
Garcia-
Aymerich et 
al. [ref 29] 
Population-
based cohort 
 
Denmark 
n=6790 
10 years 
follow-up 
43% men 
mean age: 52 (12) y 
mean FEV1: 2.7 (0.9) L 
mean FVC: 3.3 (1.0) L 
Validated 
questionnaire 
COPD 
incidence 
(FEV1/FVC≤70
%) 
Active smokers with moderate to high physical activity show a 
reduced risk of developing COPD as compared to the low physical 
activity group (OR=0.77, p=0.027). 
 
Based on logistic regression models adjusted for gender, age, 
education, body mass index, weight change during follow-up, 
asthma, dyspnea, sputum, smoking status, and smoking duration. 
 
No association found in former or never smokers. 
41 
 
FEV1 and  FVC 
decline (mL/y) 
Active smokers with moderate and high physical activity show a 
reduced FEV1 decline compared to those with low physical activity 
(relative change of +2.6 and +4.8 mL/y of FEV1, p-for-trend=0.006) 
 
Active smokers with moderate and high physical activity show a 
reduced FVC decline compared to those with low physical activity 
(relative change of +2.6 and +7.7 mL/y of FVC, p-for-trend<0.0001) 
 
Based on linear regression models adjusted for gender, age, 
education, body mass index, weight change during follow-up, 
ischemic heart disease, dyspnea, sputum, smoking status, smoking 
duration, alcohol consumption, and baseline lung function levels. 
 
No association found in former or never smokers. 
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Garcia-
Aymerich et 
al. [ref 30] 
Population-
based cohort 
 
Denmark 
n=6568 
mean 16 
years follow-
up 
41% men 
mean age: 49 (11) y 
mean FEV1: 2.7 (0.8) L 
mean FVC: 3.4 (1.0) L 
Validated 
questionnaire 
COPD 
incidence 
(FEV1/FVC≤70
%) 
Subjects with moderate to high physical activity show a reduced 
risk of developing COPD as compared to the low physical activity 
group (OR=0.79, p=0.025). 
 
Based on a logistic regression model adjusted for gender, age, 
education, body mass index, sputum, asthma and smoking, and 
weighted using marginal structural models to allow repeated 
measures of physical activity, lung function, and covariates. 
FEV1 and  FVC 
decline (mL/y) 
Subjects with moderate and high physical activity show a reduced 
FEV1 decline compared to those with low physical activity (relative 
change of +7.4 and +10.3 mL/y of FEV1, p-for-trend<0.001) 
 
Subjects with moderate and high physical activity show a reduced 
FVC decline compared to those with low physical activity (relative 
change of +6.9 and +10.0 mL/y of FVC, p-for-trend<0.001) 
 
Based on linear regression models adjusted for gender, age, 
education, body mass index, sputum, smoking, alcohol and 
baseline lung function levels, and weighted using marginal 
structural models to allow repeated measures of physical activity, 
lung function, and covariates. 
 
43 
 
Table 2. Relationship between FEV1 and physical activity in some representative cross-sectional studies. 
Study Design and 
setting  
Number of 
subjects 
(male/female) 
Physical activity 
assessment 
Main objective R 
value 
P value Main results  
Steele et 
al.  
[ref 39] 
Single-
center  
convenience 
sample 
US 
47 (44/3) Accelerometer Feasibility of 
accelerometer 
measurement  
0.62 P<0.001 Preliminary data suggesting that a triaxial movement 
sensor is a reliable, valid, and stable measure of 
walking and daily physical activity in COPD patients. 
Belza et al. 
[ref 91 ] 
Single-
center  
convenience 
sample 
US 
63(60/3) Accelerometer Evaluation of 
correlates of 
physical 
activity 
0.37 P<0.01 Physical activity is most significantly related to walking 
abilities 
Pitta et al. Single-
center  
50 (36/14) Accelerometer Comparison 
of physical 
0.28 p<0.05 Patients with COPD are markedly inactive in daily life. 
Functional exercise capacity is the strongest correlate 
44 
 
[ref 74] convenience 
sample 
Belgium 
activity in 
COPD with 
healthy 
subjects 
of physical activity. 
Walker et 
al. 
[ref 80] 
Single-
center  
convenience 
sample 
UK 
23 (12/11) Accelerometer Evaluation of 
lower limb 
activity and 
the 
association of 
laboratory 
assessments 
with physical 
activity before 
and after 
rehabilitation 
in COPD   
0.57 P<0.001 Physical activity in patients with COPD is closely 
related to leg activity, which is reduced compared with 
controls of similar age. 
Hernandes 
[ref 77] 
Single-
center  
convenience 
40 (18/22) Accelerometer Evaluation of 
physical 
activity and its 
0.17 P=ns Physical activity correlates only moderately with 
maximal and functional exercise capacity. 
45 
 
sample 
Brazil 
 
clinical 
correlates in 
COPD in 
Brazil 
Watz et al. 
[ref 65] 
Single-
center  
convenience 
sample 
Germany 
 
163 (122/41) Accelerometer Various 
analyses of 
physical 
activity and its 
clinical 
correlates in 
COPD 
0.42 P<0.01 Clinical characteristics of patients with COPD only 
incompletely reflect their physical activity 
Waschki et 
al.  
[ref 79] 
Multi-center  
convenience 
sample 
UK, 
Netherlands 
127(79/48) Accelerometer Evaluation of 
compliance 
with wearing 
an 
accelerometer 
and the 
relationship of 
disease 
0.65* P<0.001 Excellent compliance with wearing a physical activity 
monitor in a multicenter study.  
Consistent associations of physical activity with 
relevant disease characteristics in a multicenter study.  
46 
 
characteristics 
with physical 
activity in a 
multi-center 
study  
* Standardized regression coefficient beta adjusted for age, sex, study site, and BMI > 30  
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Table 3. Relationship between exercise tolerance and physical activity in some representative cross sectional studies. 
Study Design and 
setting  
Number 
of 
subjects 
(male/ 
female) 
 
Main objective Physical 
activity 
assessment  
Exercise 
tolerance 
assessment 
R 
value  
P value Main results 
Steele et al.  
[ref 39] 
Single-center  
convenience 
sample 
US 
47 (44/3) Feasibility of 
accelerometer 
measurement  
Accelerometer 6MWD 0.74 P<0.001 Preliminary data 
suggesting that a triaxial 
movement sensor is a 
reliable, valid, and stable 
measure of walking and 
daily physical activity in 
COPD patients. 
48 
 
Belza et al. 
[ref 91 ] 
Single-center  
convenience 
sample 
US 
63(60/3) Evaluation of correlates 
of physical activity 
Accelerometer  6MWD 0.60 P< 0.001 Physical activity is most 
significantly related to 
walking abilities 
Pitta et 
al. 
[ref 74] 
 
Single-center  
convenience 
sample 
Belgium 
50 
 (36/14) 
Comparison of 
physical activity in 
COPD with healthy 
subjects 
Acclerometer 6MWD, % 
pred.  
Wmax, % 
pred. 
 
Peak VO2, 
% pred.  
0.76 
 
0.64 
 
 
0.33 
P<0.0001 
 
P<0.0001 
 
 
 
Patients with COPD 
are markedly 
inactive in daily life. 
Functional exercise 
capacity is the 
strongest correlate 
of physical activity. 
Eliason 
et al. 
[ref 96] 
Multi-center  
convenience 
sample 
Sweden 
44 
 (28/16) 
Associations 
between physical 
activity and clinical 
characteristics of 
COPD  
Accelerometer 6MWD 0.34* P=0.03 Mean physical 
activity level and 
physical activity of at 
least moderate 
intensity are 
positively associated 
49 
 
with exercise 
capacity 
Waschki 
et al. 
[ref 79] 
 
Multi-center  
convenience 
sample 
UK, 
Netherlands 
127 
(79/48) 
Evaluation of compliance 
with wearing an 
accelerometer and the 
relationship of disease 
characteristics with 
physical activity in a 
multi-center study  
Accelerometer 6MWD 0.47** P<0.001 Excellent compliance 
with wearing a physical 
activity monitor in a 
multicenter study.  
Consistent 
associations of 
physical activity with 
relevant disease 
characteristics in a 
multicenter study. 
Watz et 
al. 
[ref 65] 
 
Single-center  
convenience 
sample 
Germany 
 
163 
(122/41) 
Various analyses of 
physical activity and 
its clinical correlates 
in COPD 
Accelerometer 6MWD 0.46 P<0.001 Relation to clinical 
outcomes 
50 
 
Van 
Gestel 
et al. 
[ref 40] 
 
Single-center  
convenience 
sample 
Switzerland 
 
70 
(49/21) 
 
Predicting physical 
activity levels from 
6MWD 
Accelerometer 6MWD 0.69 P<0.001 6MWD cannot 
reliably predict 
physical inactivity 
 
6MWD, 6-minute walk distance; Wmax, maximal workload; peak VO2, peak oxygen uptake; * standardized regression coefficient beta; ** standardized regression coefficient beta 
adjusted for age, sex, study site, and BMI > 30    
 
 
 
 
